Human medicines European public assessment report EPAR Miglustat Gen.Orph miglustat Gaucher Disease Date of authorisation 09112017 Revision 3 Status Authorised

Human medicines European public assessment report (EPAR): Miglustat Gen.Orph, miglustat, Gaucher Disease, Date of authorisation: 09/11/2017, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Miglustat Gen.Orph, miglustat, Gaucher Disease, Date of authorisation: 09/11/2017, Revision: 3, Status: Authorised

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Miglustat Gen.Orph, miglustat, Gaucher Disease, Date of authorisation: 09/11/2017, Revision: 3, Status: Authorised"